Manufacturer's Product Description
Selective Kinase Response Modulators for Healthy Insulin Function
Insinase features selective kinase response modulators (SKRMs)—RIAA and acacia—which have been clinically shown in a preliminary study at the FMRC* to improve fasting insulin and lipid parameters.
- Ground-breaking preliminary research suggests that SKRMs modulate kinase signals in favor of good health
- Designed to modulate kinase signaling (within cells) in favor of healthy insulin function and blood sugar transport
- Balanced kinase signaling helps to maintain healthy blood sugar and triglyceride regulation
- Developed through the ExpresSyn® Process—which combines proteomic research, safety evaluations, and human clinical research to set a new standard of clinical certainty in nutritional supplements
Three tablets daily or as directed by your healthcare provider.
|THREE TABLETS SUPPLY:|
|A proprietary blend of:||540 mg|
|Reduced Iso-Alpha Acids|
|Acacia Bark and Heartwood Extract (Acacia nilotica)|
Microcrystalline cellulose, cellulose, stearic acid, croscarmellose sodium, sodium starch glycolate, silica, and coating (deionized water, hypromellose, maltodextrin, polyethelene glycol, and sodium copper chlorophyllin).
*FMRC (Functional Medicine Research CenterSM) is the clinical research arm of Metagenics.
These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat cure, or prevent any diseases.